P01-55 The effect of topiramate in the treatment of opioid (Heroin) withdrawal - 17/03/09
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
| pages | 1 |
| Iconographies | 0 |
| Vidéos | 0 |
| Autres | 0 |
Résumé |
Objective |
This study was carried out on 149 of Heroin dependent patient that admission for detoxification.
Design |
This study is a 10 days double blind placebo-controlled trial.
Place & duration of study |
This study is a 10 days double blind placebo-controlled trial which was carried out on 149 of Heroin dependent patient that admission for detoxification in Mashhad Ebne-sina hospital in 1385-1386 Subjects were randomly divided into topiramate and placebo detoxification groups.
Subjects & methods |
Topiramate group receive topiramate (max 200 mg) for 10 days. The placebo group received usual regimen and placebo. Withdrawal symptoms were assessed by Subjective and Objective Opiate Withdrawal Scale in days 1, 3, 5, 7, 10.information s analyzed by chi-square test for qualities variables and T-test & Mann-Whitney for quantities variables in SPSS software.
Results |
22 subjects were excluded from the study. Both groups had no significant differences in age, sex, education, number of previous withdrawal and past history of other drug use. Result indicates decrease in objective withdrawal symptom significant in 3(p=0.000), 5 (p=0.004) and 7(p=0.026) day and subjective withdrawal symptom significant in 3 (p=0.000) day in topiramate groups.
Conclusion |
Topiramate can use for control of withdrawal symptom in patient with Heroin dependency.
Le texte complet de cet article est disponible en PDF.Key words : withdrawal, detoxification, topiramate, Opium, Heroin
Vol 24 - N° S1
P. S443 - 2009 Retour au numéro
Article précédent
- P01-54 Computer-assisted self-infusion of ethanol (case): New outcome measures may contain unseful information
- I. Mick, S. O’Connor, V. Vitvitsky, M.H. Plawecki, K.F. Mann, U.S. Zimmermann
- P01-56 Effects of methadone therapy on changing of positive and negative mood affect in addicted people
- S.J. Mosavi Amiri, A. Homayuoni, S. Soleimani Amiri, G.A. Nikpour, A. Khanmohammadi
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’achat d’article à l’unité est indisponible à l’heure actuelle.
Déjà abonné à cette revue ?